ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Novo prices oral Rybelsus on par with injectable rivals, ending discount fears
September 26, 2019Novo will be working to secure payer coverage as quickly as possible as part of the “strike model” it intends to use for Rybelsus’ rollout in the U.S. As it did with Ozempic, the company will start out targeting specialists, only moving to primary care ph
Pharma Sources Insight January 2025
